Table 3.
Multivariate analysis for potential prognostic factors
| Loco-regional PFS | Distant PFS | Global PFS | Overall Survival | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Characteristics | OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value |
| Gender | 0,41 | 0,03–4,94 | 0,4804 | 1,16 | 0,15–8,71 | 0,8880 | 0,80 | 0,09–6,83 | 0,8367 | 4,31 | 0,56–32,84 | 0,1591 |
| Age | 1,02 | 0,90–1,15 | 0,7026 | 0,92 | 0,83–1,02 | 0,1201 | 0,88 | 0,78–0,99 | 0,0413 | 1,04 | 0,93–1,15 | 0,4658 |
| Baseline SULpeak of T | 0,87 | 0,75–0,99 | 0,0489 | |||||||||
| Baseline SULpeak of N | 1,16 | 0,97–1,38 | 0,0984 | |||||||||
| Early metabolic response | 0,14 | 0,02–0,82 | 0,0292 | 0,15 | 0,03–0,71 | 0,0171 | 0,05 | 0,00–0,41 | 0,0059 | 0,24 | 0,05–1,06 | 0,0608 |
| Surgery | 0,14 | 0,02–0,91 | 0,0399 | 0,04 | 0,00–0,44 | 0,0093 | 0,23 | 0,03–1,39 | 0,1093 | |||
SUL peak standardized uptake value corrected for lean body mass, PFS progression free survival, OR Odds ratio, CI confidence interval, T primary tumour, N lymph-node